Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02420067 : Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
PhaseN/A
AgesMin: 15 Years Max: N/A
Eligibility
Inclusion Criteria:

- A diagnosis of vHL (either a carrier of a VHL mutation or vHL diagnosed by clinical
criteria, i.e. at least two vHL-related manifestations diagnosed or one vHL-related
manifestation diagnosed AND a first-degree relative with vHL)

- At least one audiological examination (including an audiogramme) and one MRI
examination of the brain also visualizing the inner ear within 12 months of each
other

Exclusion Criteria:

- Children under the age of 15 years
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02420067      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740